syndrome	score	normalized_score
45,X/46,XY MIXED GONADAL DYSGENESIS	0.11782240999999999	100.0
ELSAHY-WATERS SYNDROME; ESWS	0.11165655399999999	94.76682237275574
SPONDYLOCOSTAL DYSOSTOSIS-HYPOSPADIAS-INTELLECTUAL DISABILITY SYNDROME	0.11111099999999999	94.30379161315746
3MC SYNDROME 3	0.11111099999999999	94.30379161315746
BRANCHIOSKELETOGENITAL SYNDROME	0.11111099999999999	94.30379161315746
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.11111099999999999	94.30379161315746
46,XY SEX REVERSAL 3	0.11111099999999999	94.30379161315746
46,XX SEX REVERSAL 4; SRXX4	0.11111099999999999	94.30379161315746
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.007256964	6.159239146440818
HYPERPROLINEMIA, TYPE I	0.007256964	6.159239146440818
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.007256964	6.159239146440818
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.007256964	6.159239146440818
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.007256964	6.159239146440818
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.007256964	6.159239146440818
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.007256964	6.159239146440818
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.007256964	6.159239146440818
DOORS SYNDROME	0.007256964	6.159239146440818
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.007256964	6.159239146440818
SHUKLA-VERNON SYNDROME; SHUVER	0.007256964	6.159239146440818
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007256964	6.159239146440818
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	6.159239146440818
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.007256964	6.159239146440818
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.007256964	6.159239146440818
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.007256964	6.159239146440818
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007256964	6.159239146440818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.007256964	6.159239146440818
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.007256964	6.159239146440818
FRIED SYNDROME	0.007256964	6.159239146440818
RING CHROMOSOME 22 SYNDROME	0.007256964	6.159239146440818
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.007256964	6.159239146440818
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007256964	6.159239146440818
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.007256964	6.159239146440818
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.007256964	6.159239146440818
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.007256964	6.159239146440818
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007256964	6.159239146440818
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.007256964	6.159239146440818
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.007256964	6.159239146440818
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	6.159239146440818
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.007256964	6.159239146440818
TURNPENNY-FRY SYNDROME; TPFS	0.007256964	6.159239146440818
XQ25 MICRODUPLICATION SYNDROME	0.007256964	6.159239146440818
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.007256964	6.159239146440818
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007256964	6.159239146440818
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.007256964	6.159239146440818
LUSCAN-LUMISH SYNDROME; LLS	0.007256964	6.159239146440818
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.007256964	6.159239146440818
16P13.2 MICRODELETION SYNDROME	0.007256964	6.159239146440818
RAYNAUD-CLAES SYNDROME; MRXSRC	0.007256964	6.159239146440818
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.007256964	6.159239146440818
CHROMOSOME 16P13.2 DELETION SYNDROME	0.007256964	6.159239146440818
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.007256964	6.159239146440818
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.007256964	6.159239146440818
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.007256964	6.159239146440818
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.007256964	6.159239146440818
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.007256964	6.159239146440818
MONOSOMY 22Q13.3	0.007256964	6.159239146440818
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.007256964	6.159239146440818
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.007256964	6.159239146440818
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.007256964	6.159239146440818
PRADER-WILLI-LIKE SYNDROME	0.007256964	6.159239146440818
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.007256964	6.159239146440818
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.007256964	6.159239146440818
1P21.3 MICRODELETION SYNDROME	0.007256964	6.159239146440818
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.007256964	6.159239146440818
COFFIN-SIRIS SYNDROME 1; CSS1	0.007256964	6.159239146440818
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.007256964	6.159239146440818
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	6.159239146440818
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.007256964	6.159239146440818
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.007256964	6.159239146440818
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.007256964	6.159239146440818
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.007256964	6.159239146440818
MYOCLONIC-ASTASTIC EPILEPSY	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.007256964	6.159239146440818
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.007256964	6.159239146440818
KLEEFSTRA SYNDROME 2; KLEFS2	0.007256964	6.159239146440818
TETRASOMY 9P	0.007256964	6.159239146440818
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.007256964	6.159239146440818
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.007256964	6.159239146440818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.007256964	6.159239146440818
OBESITY DUE TO SIM1 DEFICIENCY	0.007256964	6.159239146440818
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.007256964	6.159239146440818
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.007256964	6.159239146440818
OGDEN SYNDROME	0.007256964	6.159239146440818
DISTAL MONOSOMY 15Q	0.007256964	6.159239146440818
HELSMOORTEL-VAN DER AA SYNDROME	0.007256964	6.159239146440818
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.007256964	6.159239146440818
KLEEFSTRA SYNDROME	0.007256964	6.159239146440818
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007256964	6.159239146440818
DISTAL 16P11.2 MICRODELETION SYNDROME	0.007256964	6.159239146440818
HSD10 DISEASE	0.007256964	6.159239146440818
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.007256964	6.159239146440818
PITT-HOPKINS SYNDROME	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.007256964	6.159239146440818
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.007256964	6.159239146440818
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	6.159239146440818
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00671141	5.696208386842538
MENTAL RETARDATION, X-LINKED 82	0.00671141	5.696208386842538
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00671141	5.696208386842538
49,XXXYY SYNDROME	0.00671141	5.696208386842538
9Q21.13 MICRODELETION SYNDROME	0.00671141	5.696208386842538
XQ12-Q13.3 DUPLICATION SYNDROME	0.00671141	5.696208386842538
5Q14.3 MICRODELETION SYNDROME	0.00671141	5.696208386842538
20Q13.33 MICRODELETION SYNDROME	0.00671141	5.696208386842538
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	5.696208386842538
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00671141	5.696208386842538
LENNOX-GASTAUT SYNDROME	0.00671141	5.696208386842538
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00671141	5.696208386842538
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00671141	5.696208386842538
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00671141	5.696208386842538
STURGE-WEBER SYNDROME	0.00671141	5.696208386842538
DUPLICATION/INVERSION 15Q11	0.00671141	5.696208386842538
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.00671141	5.696208386842538
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.00671141	5.696208386842538
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.00671141	5.696208386842538
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00671141	5.696208386842538
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.00671141	5.696208386842538
46,XY SEX REVERSAL 9; SRXY9	0.00671141	5.696208386842538
3P25.3 MICRODELETION SYNDROME	0.00671141	5.696208386842538
RETT SYNDROME; RTT	0.00671141	5.696208386842538
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00671141	5.696208386842538
MICROPHTHALMIA, SYNDROMIC 1	0.00671141	5.696208386842538
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00671141	5.696208386842538
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.00671141	5.696208386842538
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00671141	5.696208386842538
2Q24 MICRODELETION SYNDROME	0.00671141	5.696208386842538
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	5.696208386842538
COG5-CDG	0.00671141	5.696208386842538
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.00671141	5.696208386842538
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00671141	5.696208386842538
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.00671141	5.696208386842538
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.00671141	5.696208386842538
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00671141	5.696208386842538
FRAXE INTELLECTUAL DISABILITY	0.00671141	5.696208386842538
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.00671141	5.696208386842538
CHILDHOOD APRAXIA OF SPEECH	0.00671141	5.696208386842538
DRAVET SYNDROME	0.00671141	5.696208386842538
WOLFRAM-LIKE SYNDROME	0.00671141	5.696208386842538
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00671141	5.696208386842538
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	5.696208386842538
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00671141	5.696208386842538
HYPERTELORISM, TEEBI TYPE; TBHS	0.00671141	5.696208386842538
SILVER-RUSSELL SYNDROME	0.00671141	5.696208386842538
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00671141	5.696208386842538
PRADER-WILLI SYNDROME	0.00671141	5.696208386842538
ZECHI-CEIDE SYNDROME	0.000545554	0.46303075959828016
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.000545554	0.46303075959828016
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.46303075959828016
HOLOPROSENCEPHALY	0.000545554	0.46303075959828016
DONNAI-BARROW SYNDROME	0.000545554	0.46303075959828016
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.46303075959828016
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.46303075959828016
HARTNUP DISEASE	0.000545554	0.46303075959828016
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.46303075959828016
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000545554	0.46303075959828016
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.46303075959828016
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.46303075959828016
CUTIS LAXA	0.000545554	0.46303075959828016
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000545554	0.46303075959828016
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.46303075959828016
HYDRANENCEPHALY	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.46303075959828016
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.46303075959828016
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.46303075959828016
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.46303075959828016
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.46303075959828016
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.46303075959828016
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.46303075959828016
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
NEPHROGENIC DIABETES INSIPIDUS	0.000545554	0.46303075959828016
HYPERTRICHOSIS CUBITI	0.000545554	0.46303075959828016
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.46303075959828016
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.46303075959828016
MATERNAL PHENYLKETONURIA	0.000545554	0.46303075959828016
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.000545554	0.46303075959828016
JOUBERT SYNDROME WITH RENAL DEFECT	0.000545554	0.46303075959828016
JOUBERT SYNDROME WITH OCULAR DEFECT	0.000545554	0.46303075959828016
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.46303075959828016
OPTIC PATHWAY GLIOMA	0.000545554	0.46303075959828016
GERODERMA OSTEODYSPLASTICA	0.000545554	0.46303075959828016
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.46303075959828016
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.46303075959828016
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.46303075959828016
FETAL ALCOHOL SYNDROME	0.000545554	0.46303075959828016
FETAL TRIMETHADIONE SYNDROME	0.000545554	0.46303075959828016
FETAL HYDANTOIN SYNDROME	0.000545554	0.46303075959828016
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.000545554	0.46303075959828016
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.46303075959828016
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.46303075959828016
TEMTAMY SYNDROME	0.000545554	0.46303075959828016
COHEN SYNDROME	0.000545554	0.46303075959828016
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.46303075959828016
DYSKERATOSIS CONGENITA	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000545554	0.46303075959828016
TRISOMY 8Q	0.000545554	0.46303075959828016
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000545554	0.46303075959828016
DISTAL TRISOMY 6P	0.000545554	0.46303075959828016
22Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
TOLUENE EMBRYOPATHY	0.000545554	0.46303075959828016
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000545554	0.46303075959828016
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.46303075959828016
COWDEN SYNDROME	0.000545554	0.46303075959828016
GERMAN SYNDROME	0.000545554	0.46303075959828016
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME	0.000545554	0.46303075959828016
COLE-CARPENTER SYNDROME	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.46303075959828016
FOIX-CHAVANY-MARIE SYNDROME	0.000545554	0.46303075959828016
FLOATING-HARBOR SYNDROME	0.000545554	0.46303075959828016
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.46303075959828016
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.000545554	0.46303075959828016
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.46303075959828016
EAST SYNDROME	0.000545554	0.46303075959828016
OCCIPITAL HORN SYNDROME	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.000545554	0.46303075959828016
EARLY MYOCLONIC ENCEPHALOPATHY	0.000545554	0.46303075959828016
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.000545554	0.46303075959828016
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.46303075959828016
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
ICF SYNDROME	0.000545554	0.46303075959828016
AL KAISSI SYNDROME; ALKAS	0.000545554	0.46303075959828016
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.46303075959828016
MONOSOMY 9P	0.000545554	0.46303075959828016
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.46303075959828016
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.46303075959828016
N SYNDROME	0.000545554	0.46303075959828016
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.000545554	0.46303075959828016
MIETENS SYNDROME	0.000545554	0.46303075959828016
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.000545554	0.46303075959828016
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.46303075959828016
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.46303075959828016
KAGAMI-OGATA SYNDROME	0.000545554	0.46303075959828016
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.46303075959828016
19P13.12 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.46303075959828016
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.46303075959828016
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.000545554	0.46303075959828016
15Q14 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
CK SYNDROME	0.000545554	0.46303075959828016
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000545554	0.46303075959828016
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.46303075959828016
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.46303075959828016
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.46303075959828016
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.46303075959828016
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.46303075959828016
XP21 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
2P15P16.1 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
16P11.2P12.2 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.46303075959828016
20P12.3 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
TRISOMY 17P	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.000545554	0.46303075959828016
17Q12 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
16P13.11 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000545554	0.46303075959828016
DUANE RETRACTION SYNDROME	0.000545554	0.46303075959828016
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.46303075959828016
1Q44 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.46303075959828016
15Q11Q13 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000545554	0.46303075959828016
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.46303075959828016
TRISOMY 9P	0.000545554	0.46303075959828016
KBG SYNDROME	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.000545554	0.46303075959828016
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000545554	0.46303075959828016
USHER SYNDROME TYPE 1	0.000545554	0.46303075959828016
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.000545554	0.46303075959828016
JACOBSEN SYNDROME	0.000545554	0.46303075959828016
MICROVILLUS INCLUSION DISEASE	0.000545554	0.46303075959828016
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.46303075959828016
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.46303075959828016
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.000545554	0.46303075959828016
RFT1-CDG	0.000545554	0.46303075959828016
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.46303075959828016
1Q21.1 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
8P23.1 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
8P11.2 DELETION SYNDROME	0.000545554	0.46303075959828016
6Q25 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
3Q29 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
2Q32Q33 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
2Q31.1 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
MICRO SYNDROME	0.000545554	0.46303075959828016
1Q21.1 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000545554	0.46303075959828016
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.46303075959828016
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.46303075959828016
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
CITRULLINEMIA TYPE II	0.000545554	0.46303075959828016
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000545554	0.46303075959828016
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
MARDEN-WALKER SYNDROME	0.000545554	0.46303075959828016
6Q16 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
MOSAIC TRISOMY 14	0.000545554	0.46303075959828016
DISTAL TRISOMY 18Q	0.000545554	0.46303075959828016
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.46303075959828016
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000545554	0.46303075959828016
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000545554	0.46303075959828016
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.46303075959828016
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.46303075959828016
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000545554	0.46303075959828016
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000545554	0.46303075959828016
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.46303075959828016
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.46303075959828016
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000545554	0.46303075959828016
POPOV-CHANG SYNDROME; POPCHAS	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000545554	0.46303075959828016
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.46303075959828016
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.000545554	0.46303075959828016
2Q37 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000545554	0.46303075959828016
48,XXYY SYNDROME	0.000545554	0.46303075959828016
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.46303075959828016
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000545554	0.46303075959828016
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000545554	0.46303075959828016
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.46303075959828016
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.46303075959828016
NOONAN SYNDROME 11; NS11	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.46303075959828016
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.46303075959828016
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.000545554	0.46303075959828016
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.46303075959828016
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.46303075959828016
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.46303075959828016
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.000545554	0.46303075959828016
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.46303075959828016
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.000545554	0.46303075959828016
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.000545554	0.46303075959828016
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.46303075959828016
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000545554	0.46303075959828016
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.46303075959828016
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.46303075959828016
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.46303075959828016
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.000545554	0.46303075959828016
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.000545554	0.46303075959828016
CHROMOSOME 1P35 DELETION SYNDROME	0.000545554	0.46303075959828016
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000545554	0.46303075959828016
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000545554	0.46303075959828016
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.46303075959828016
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.46303075959828016
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.46303075959828016
VICI SYNDROME	0.000545554	0.46303075959828016
MONOSOMY 18Q	0.000545554	0.46303075959828016
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.46303075959828016
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.46303075959828016
COFFIN-SIRIS SYNDROME	0.000545554	0.46303075959828016
CODAS SYNDROME	0.000545554	0.46303075959828016
CINCA SYNDROME	0.000545554	0.46303075959828016
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000545554	0.46303075959828016
MONOSOMY 18P	0.000545554	0.46303075959828016
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.000545554	0.46303075959828016
DISTAL MONOSOMY 9P	0.000545554	0.46303075959828016
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.46303075959828016
TRISOMY 12P	0.000545554	0.46303075959828016
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.000545554	0.46303075959828016
CHÉDIAK-HIGASHI SYNDROME	0.000545554	0.46303075959828016
DEXTROCARDIA	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.46303075959828016
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.46303075959828016
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000545554	0.46303075959828016
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000545554	0.46303075959828016
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.46303075959828016
2P21 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000545554	0.46303075959828016
1P36 DELETION SYNDROME	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.46303075959828016
RING CHROMOSOME 12 SYNDROME	0.000545554	0.46303075959828016
XQ21 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
CANAVAN DISEASE	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000545554	0.46303075959828016
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.46303075959828016
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
PENTASOMY X	0.000545554	0.46303075959828016
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000545554	0.46303075959828016
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000545554	0.46303075959828016
17Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.46303075959828016
TRANSALDOLASE DEFICIENCY	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.46303075959828016
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000545554	0.46303075959828016
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.46303075959828016
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.46303075959828016
AYMÉ-GRIPP SYNDROME	0.000545554	0.46303075959828016
JABERI-ELAHI SYNDROME; JABELS	0.000545554	0.46303075959828016
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.46303075959828016
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.46303075959828016
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.46303075959828016
CHARGE SYNDROME	0.000545554	0.46303075959828016
AURICULOCONDYLAR SYNDROME	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.000545554	0.46303075959828016
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION	0.000545554	0.46303075959828016
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000545554	0.46303075959828016
HYPEREKPLEXIA 4; HKPX4	0.000545554	0.46303075959828016
CARDIOFACIOCUTANEOUS SYNDROME	0.000545554	0.46303075959828016
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000545554	0.46303075959828016
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000545554	0.46303075959828016
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.46303075959828016
WRINKLY SKIN SYNDROME	0.000545554	0.46303075959828016
COG4-CDG	0.000545554	0.46303075959828016
ALSTRÖM SYNDROME	0.000545554	0.46303075959828016
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.46303075959828016
3C SYNDROME	0.000545554	0.46303075959828016
PALLISTER-HALL SYNDROME	0.000545554	0.46303075959828016
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.46303075959828016
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000545554	0.46303075959828016
CEDNIK SYNDROME	0.000545554	0.46303075959828016
LEBER CONGENITAL AMAUROSIS	0.000545554	0.46303075959828016
NIEMANN-PICK DISEASE TYPE C	0.000545554	0.46303075959828016
NARP SYNDROME	0.000545554	0.46303075959828016
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.46303075959828016
NETHERTON SYNDROME	0.000545554	0.46303075959828016
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.46303075959828016
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000545554	0.46303075959828016
MEDULLOBLASTOMA	0.000545554	0.46303075959828016
ALPHA-MANNOSIDOSIS	0.000545554	0.46303075959828016
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.46303075959828016
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.46303075959828016
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000545554	0.46303075959828016
22Q11.2 DELETION SYNDROME	0.000545554	0.46303075959828016
ATELOSTEOGENESIS TYPE III	0.000545554	0.46303075959828016
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.46303075959828016
CRANIOPHARYNGIOMA	0.000545554	0.46303075959828016
PETERS PLUS SYNDROME	0.000545554	0.46303075959828016
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000545554	0.46303075959828016
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.46303075959828016
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.46303075959828016
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000545554	0.46303075959828016
CLASSIC PHENYLKETONURIA	0.000545554	0.46303075959828016
BIOTINIDASE DEFICIENCY	0.000545554	0.46303075959828016
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.46303075959828016
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.46303075959828016
HYDROXYKYNURENINURIA	0.000545554	0.46303075959828016
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.000545554	0.46303075959828016
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.46303075959828016
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.000545554	0.46303075959828016
RUBINSTEIN-TAYBI SYNDROME	0.000545554	0.46303075959828016
MONOSOMY 9Q22.3	0.000545554	0.46303075959828016
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.46303075959828016
INFANTILE REFSUM DISEASE	0.000545554	0.46303075959828016
RABSON-MENDENHALL SYNDROME	0.000545554	0.46303075959828016
PYRUVATE DEHYDROGENASE DEFICIENCY	0.000545554	0.46303075959828016
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.46303075959828016
6Q TERMINAL DELETION SYNDROME	0.000545554	0.46303075959828016
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.46303075959828016
WOLMAN DISEASE	0.000545554	0.46303075959828016
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.46303075959828016
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.46303075959828016
WYBURN-MASON SYNDROME	0.000545554	0.46303075959828016
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.46303075959828016
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.000545554	0.46303075959828016
CHAR SYNDROME	0.000545554	0.46303075959828016
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.46303075959828016
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.46303075959828016
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
JOUBERT SYNDROME	0.000545554	0.46303075959828016
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.46303075959828016
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.000545554	0.46303075959828016
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000545554	0.46303075959828016
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.46303075959828016
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.46303075959828016
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000545554	0.46303075959828016
INCONTINENTIA PIGMENTI	0.000545554	0.46303075959828016
LATHOSTEROLOSIS	0.000545554	0.46303075959828016
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.46303075959828016
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.000545554	0.46303075959828016
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.000545554	0.46303075959828016
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.46303075959828016
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.000545554	0.46303075959828016
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.000545554	0.46303075959828016
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.46303075959828016
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.46303075959828016
KRABBE DISEASE	0.000545554	0.46303075959828016
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.46303075959828016
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.000545554	0.46303075959828016
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.46303075959828016
MAPLE SYRUP URINE DISEASE	0.000545554	0.46303075959828016
AICARDI-GOUTIÈRES SYNDROME	0.000545554	0.46303075959828016
8Q24.3 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.46303075959828016
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.46303075959828016
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.46303075959828016
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000545554	0.46303075959828016
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.000545554	0.46303075959828016
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.46303075959828016
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.46303075959828016
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.46303075959828016
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.46303075959828016
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.46303075959828016
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.000545554	0.46303075959828016
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
TRANSKETOLASE DEFICIENCY	0.000545554	0.46303075959828016
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.000545554	0.46303075959828016
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.000545554	0.46303075959828016
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.46303075959828016
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.000545554	0.46303075959828016
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.46303075959828016
RECOMBINANT 8 SYNDROME	0.000545554	0.46303075959828016
DISTAL MONOSOMY 12Q	0.000545554	0.46303075959828016
DISTAL MONOSOMY 10Q	0.000545554	0.46303075959828016
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.000545554	0.46303075959828016
DISTAL MONOSOMY 19P13.3	0.000545554	0.46303075959828016
DISTAL MONOSOMY 6P	0.000545554	0.46303075959828016
THYROID HYPOPLASIA	0.000545554	0.46303075959828016
THYROID HEMIAGENESIS	0.000545554	0.46303075959828016
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.46303075959828016
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.46303075959828016
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.46303075959828016
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.46303075959828016
ATHYREOSIS	0.000545554	0.46303075959828016
THYROID ECTOPIA	0.000545554	0.46303075959828016
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.46303075959828016
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.46303075959828016
15Q24 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
HOLMES-GANG SYNDROME	0.000545554	0.46303075959828016
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.46303075959828016
FG SYNDROME TYPE 1	0.000545554	0.46303075959828016
HURLER SYNDROME	0.000545554	0.46303075959828016
MONOSOMY 13Q34	0.000545554	0.46303075959828016
KOOLEN-DE VRIES SYNDROME	0.000545554	0.46303075959828016
EMANUEL SYNDROME	0.000545554	0.46303075959828016
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.46303075959828016
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.46303075959828016
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.46303075959828016
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.46303075959828016
LIG4 SYNDROME	0.000545554	0.46303075959828016
MOSAIC TRISOMY 9	0.000545554	0.46303075959828016
48,XYYY SYNDROME	0.000545554	0.46303075959828016
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.46303075959828016
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.46303075959828016
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.46303075959828016
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.46303075959828016
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000545554	0.46303075959828016
BOHRING-OPITZ SYNDROME	0.000545554	0.46303075959828016
RIGID SPINE SYNDROME	0.000545554	0.46303075959828016
ZEBRA BODY MYOPATHY	0.000545554	0.46303075959828016
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.46303075959828016
49,XXXXY SYNDROME	0.000545554	0.46303075959828016
48,XXXY SYNDROME	0.000545554	0.46303075959828016
X SMALL RINGS	0.000545554	0.46303075959828016
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.46303075959828016
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.46303075959828016
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.46303075959828016
PFEIFFER SYNDROME TYPE 2	0.000545554	0.46303075959828016
PMM2-CDG	0.000545554	0.46303075959828016
FANCONI ANEMIA	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.46303075959828016
BRESEK SYNDROME	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000545554	0.46303075959828016
KEUTEL SYNDROME	0.000545554	0.46303075959828016
GENITOPATELLAR SYNDROME	0.000545554	0.46303075959828016
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.46303075959828016
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.46303075959828016
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.46303075959828016
TAY-SACHS DISEASE	0.000545554	0.46303075959828016
SYNDROMIC DIARRHEA	0.000545554	0.46303075959828016
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.46303075959828016
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.46303075959828016
FREE SIALIC ACID STORAGE DISEASE	0.000545554	0.46303075959828016
SMITH-MAGENIS SYNDROME	0.000545554	0.46303075959828016
SMITH-LEMLI-OPITZ SYNDROME	0.000545554	0.46303075959828016
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.46303075959828016
SCHIZENCEPHALY	0.000545554	0.46303075959828016
GRISCELLI SYNDROME TYPE 1	0.000545554	0.46303075959828016
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.46303075959828016
ALG1-CDG	0.000545554	0.46303075959828016
ALG3-CDG	0.000545554	0.46303075959828016
ALG6-CDG	0.000545554	0.46303075959828016
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.46303075959828016
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000545554	0.46303075959828016
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000545554	0.46303075959828016
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.46303075959828016
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000545554	0.46303075959828016
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
HEREDITARY FOLATE MALABSORPTION	0.000545554	0.46303075959828016
ARGININEMIA	0.000545554	0.46303075959828016
TETRASOMY X	0.000545554	0.46303075959828016
WALKER-WARBURG SYNDROME	0.000545554	0.46303075959828016
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.46303075959828016
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.46303075959828016
SIALIDOSIS TYPE 2	0.000545554	0.46303075959828016
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.46303075959828016
DPAGT1-CDG	0.000545554	0.46303075959828016
TREACHER-COLLINS SYNDROME	0.000545554	0.46303075959828016
CONGENITAL TOXOPLASMOSIS	0.000545554	0.46303075959828016
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.46303075959828016
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.000545554	0.46303075959828016
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.46303075959828016
19P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
11P15.4 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
RUVALCABA SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.000545554	0.46303075959828016
ROBERTS SYNDROME	0.000545554	0.46303075959828016
OXOGLUTARIC ACIDURIA	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.000545554	0.46303075959828016
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.46303075959828016
PYRIDOXINE-DEPENDENT EPILEPSY	0.000545554	0.46303075959828016
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000545554	0.46303075959828016
HEREDITARY OROTIC ACIDURIA	0.000545554	0.46303075959828016
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.000545554	0.46303075959828016
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.000545554	0.46303075959828016
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000545554	0.46303075959828016
DE BARSY SYNDROME	0.000545554	0.46303075959828016
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.000545554	0.46303075959828016
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.46303075959828016
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.46303075959828016
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
CONGENITAL VARICELLA SYNDROME	0.000545554	0.46303075959828016
MEVALONIC ACIDURIA	0.000545554	0.46303075959828016
SARCOSINEMIA	0.000545554	0.46303075959828016
SAY-BARBER-MILLER SYNDROME	0.000545554	0.46303075959828016
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.000545554	0.46303075959828016
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.46303075959828016
FILIPPI SYNDROME	0.000545554	0.46303075959828016
SRD5A3-CDG	0.000545554	0.46303075959828016
ABETAL34V AMYLOIDOSIS	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000545554	0.46303075959828016
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.46303075959828016
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.46303075959828016
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.46303075959828016
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.46303075959828016
SIALURIA	0.000545554	0.46303075959828016
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.46303075959828016
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.000545554	0.46303075959828016
SENIOR-LOKEN SYNDROME	0.000545554	0.46303075959828016
SEVERE CANAVAN DISEASE	0.000545554	0.46303075959828016
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.46303075959828016
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.46303075959828016
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.46303075959828016
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.46303075959828016
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.000545554	0.46303075959828016
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000545554	0.46303075959828016
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000545554	0.46303075959828016
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
10Q22.3Q23.3 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.46303075959828016
L1 SYNDROME	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME TYPE 6	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.46303075959828016
OPITZ G/BBB SYNDROME	0.000545554	0.46303075959828016
OKAMOTO SYNDROME	0.000545554	0.46303075959828016
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.46303075959828016
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.000545554	0.46303075959828016
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000545554	0.46303075959828016
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.46303075959828016
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.46303075959828016
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000545554	0.46303075959828016
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.46303075959828016
BILATERAL POLYMICROGYRIA	0.000545554	0.46303075959828016
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.46303075959828016
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.000545554	0.46303075959828016
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000545554	0.46303075959828016
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.46303075959828016
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.46303075959828016
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.46303075959828016
TARP SYNDROME	0.000545554	0.46303075959828016
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.46303075959828016
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.46303075959828016
PERLMAN SYNDROME	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.46303075959828016
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.46303075959828016
PEHO SYNDROME	0.000545554	0.46303075959828016
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.46303075959828016
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.000545554	0.46303075959828016
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.000545554	0.46303075959828016
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.000545554	0.46303075959828016
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.46303075959828016
W SYNDROME	0.000545554	0.46303075959828016
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.46303075959828016
ALG11-CDG	0.000545554	0.46303075959828016
WOLF-HIRSCHHORN SYNDROME	0.000545554	0.46303075959828016
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.46303075959828016
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.46303075959828016
OTOFACIOCERVICAL SYNDROME	0.000545554	0.46303075959828016
LATERAL MENINGOCELE SYNDROME	0.000545554	0.46303075959828016
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.000545554	0.46303075959828016
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.000545554	0.46303075959828016
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.000545554	0.46303075959828016
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.46303075959828016
MEND SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.46303075959828016
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.46303075959828016
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.46303075959828016
MAN1B1-CDG	0.000545554	0.46303075959828016
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000545554	0.46303075959828016
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.000545554	0.46303075959828016
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.46303075959828016
GRISCELLI SYNDROME	0.000545554	0.46303075959828016
SIMPSON-GOLABI-BEHMEL SYNDROME	0.000545554	0.46303075959828016
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000545554	0.46303075959828016
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.46303075959828016
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000545554	0.46303075959828016
SALT-AND-PEPPER SYNDROME	0.000545554	0.46303075959828016
SSR4-CDG	0.000545554	0.46303075959828016
STT3B-CDG	0.000545554	0.46303075959828016
STT3A-CDG	0.000545554	0.46303075959828016
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.000545554	0.46303075959828016
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.46303075959828016
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.000545554	0.46303075959828016
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.000545554	0.46303075959828016
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.46303075959828016
11Q22.2Q22.3 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.000545554	0.46303075959828016
CONGENITAL HYPOTHYROIDISM	0.000545554	0.46303075959828016
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.46303075959828016
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.46303075959828016
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000545554	0.46303075959828016
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.000545554	0.46303075959828016
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
COG2-CDG	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.46303075959828016
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000545554	0.46303075959828016
PHACE SYNDROME	0.000545554	0.46303075959828016
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.46303075959828016
RIDDLE SYNDROME	0.000545554	0.46303075959828016
DYSTONIA-APHONIA SYNDROME	0.000545554	0.46303075959828016
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.000545554	0.46303075959828016
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.000545554	0.46303075959828016
EPIDERMAL NEVUS SYNDROME	0.000545554	0.46303075959828016
PROPIONIC ACIDEMIA	0.000545554	0.46303075959828016
FUCOSIDOSIS	0.000545554	0.46303075959828016
YUNIS-VARON SYNDROME	0.000545554	0.46303075959828016
WILSON-TURNER SYNDROME	0.000545554	0.46303075959828016
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.46303075959828016
WEAVER SYNDROME	0.000545554	0.46303075959828016
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.46303075959828016
TRISOMY 18	0.000545554	0.46303075959828016
DISTAL TRISOMY 17Q	0.000545554	0.46303075959828016
TRISOMY X	0.000545554	0.46303075959828016
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.46303075959828016
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.46303075959828016
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.000545554	0.46303075959828016
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.46303075959828016
TRICHOTHIODYSTROPHY	0.000545554	0.46303075959828016
FARBER DISEASE	0.000545554	0.46303075959828016
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.46303075959828016
TETRASOMY 5P	0.000545554	0.46303075959828016
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.46303075959828016
ISOVALERIC ACIDEMIA	0.000545554	0.46303075959828016
ISOLATED PLAGIOCEPHALY	0.000545554	0.46303075959828016
GALACTOSEMIA	0.000545554	0.46303075959828016
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.46303075959828016
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.46303075959828016
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.46303075959828016
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.000545554	0.46303075959828016
DISTAL MONOSOMY 1Q	0.000545554	0.46303075959828016
20Q11.2 MICRODUPLICATION SYNDROME	0.000545554	0.46303075959828016
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.000545554	0.46303075959828016
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.46303075959828016
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.46303075959828016
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.46303075959828016
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.46303075959828016
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.000545554	0.46303075959828016
19P13.13 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
SLC35A2-CDG	0.000545554	0.46303075959828016
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.46303075959828016
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.46303075959828016
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.46303075959828016
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.46303075959828016
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.46303075959828016
JOUBERT SYNDROME 30; JBTS30	0.000545554	0.46303075959828016
SOTOS SYNDROME	0.000545554	0.46303075959828016
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000545554	0.46303075959828016
MUENKE SYNDROME	0.000545554	0.46303075959828016
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.46303075959828016
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.46303075959828016
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.46303075959828016
PIERPONT SYNDROME	0.000545554	0.46303075959828016
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.46303075959828016
CURRY-JONES SYNDROME	0.000545554	0.46303075959828016
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.000545554	0.46303075959828016
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000545554	0.46303075959828016
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.46303075959828016
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.46303075959828016
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.46303075959828016
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.000545554	0.46303075959828016
TIMOTHY SYNDROME; TS	0.000545554	0.46303075959828016
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.46303075959828016
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.46303075959828016
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.46303075959828016
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.46303075959828016
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.46303075959828016
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.46303075959828016
CHROMOSOME 2Q37 DELETION SYNDROME	0.000545554	0.46303075959828016
CDAGS SYNDROME	0.000545554	0.46303075959828016
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.46303075959828016
CODAS SYNDROME	0.000545554	0.46303075959828016
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.46303075959828016
PHELAN-MCDERMID SYNDROME	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.46303075959828016
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000545554	0.46303075959828016
GENITOPATELLAR SYNDROME; GTPTS	0.000545554	0.46303075959828016
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.46303075959828016
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000545554	0.46303075959828016
PROPIONIC ACIDEMIA	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.46303075959828016
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.46303075959828016
FRONTOOCULAR SYNDROME	0.000545554	0.46303075959828016
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.46303075959828016
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.46303075959828016
NOONAN SYNDROME 2; NS2	0.000545554	0.46303075959828016
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.46303075959828016
WIEDEMANN-STEINER SYNDROME; WDSTS	0.000545554	0.46303075959828016
BOHRING-OPITZ SYNDROME	0.000545554	0.46303075959828016
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.46303075959828016
SALLA DISEASE	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.46303075959828016
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.000545554	0.46303075959828016
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000545554	0.46303075959828016
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.46303075959828016
BAND HETEROTOPIA; BH	0.000545554	0.46303075959828016
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.46303075959828016
CRANIOFRONTONASAL SYNDROME; CFNS	0.000545554	0.46303075959828016
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.000545554	0.46303075959828016
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000545554	0.46303075959828016
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000545554	0.46303075959828016
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 104; MRX104	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 103	0.000545554	0.46303075959828016
XQ25 DUPLICATION SYNDROME	0.000545554	0.46303075959828016
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.000545554	0.46303075959828016
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.46303075959828016
MEND SYNDROME; MEND	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.46303075959828016
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.46303075959828016
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.46303075959828016
PETTIGREW SYNDROME	0.000545554	0.46303075959828016
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.46303075959828016
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.46303075959828016
OCULOECTODERMAL SYNDROME; OES	0.000545554	0.46303075959828016
LOWRY-MACLEAN SYNDROME	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.46303075959828016
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.46303075959828016
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.46303075959828016
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.46303075959828016
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000545554	0.46303075959828016
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.46303075959828016
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000545554	0.46303075959828016
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.46303075959828016
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.46303075959828016
WIEACKER-WOLFF SYNDROME	0.000545554	0.46303075959828016
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000545554	0.46303075959828016
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.000545554	0.46303075959828016
PELIZAEUS-MERZBACHER DISEASE	0.000545554	0.46303075959828016
TARP SYNDROME; TARPS	0.000545554	0.46303075959828016
WAISMAN SYNDROME; WSMN	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.000545554	0.46303075959828016
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 9	0.000545554	0.46303075959828016
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.000545554	0.46303075959828016
GLYCEROL KINASE DEFICIENCY; GKD	0.000545554	0.46303075959828016
AARSKOG-SCOTT SYNDROME	0.000545554	0.46303075959828016
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000545554	0.46303075959828016
PHACE ASSOCIATION	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.000545554	0.46303075959828016
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000545554	0.46303075959828016
POTOCKI-LUPSKI SYNDROME	0.000545554	0.46303075959828016
HOLOPROSENCEPHALY 7	0.000545554	0.46303075959828016
CORNELIA DE LANGE SYNDROME 3	0.000545554	0.46303075959828016
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.46303075959828016
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000545554	0.46303075959828016
JOUBERT SYNDROME 6	0.000545554	0.46303075959828016
CHROMOSOME 16P13.3 DELETION SYNDROME	0.000545554	0.46303075959828016
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.46303075959828016
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.46303075959828016
KOOLEN-DE VRIES SYNDROME; KDVS	0.000545554	0.46303075959828016
MEVALONIC ACIDURIA; MEVA	0.000545554	0.46303075959828016
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000545554	0.46303075959828016
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.46303075959828016
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.46303075959828016
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.46303075959828016
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000545554	0.46303075959828016
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000545554	0.46303075959828016
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000545554	0.46303075959828016
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.46303075959828016
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000545554	0.46303075959828016
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.46303075959828016
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.46303075959828016
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.000545554	0.46303075959828016
NOONAN SYNDROME 3; NS3	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.000545554	0.46303075959828016
GLASS SYNDROME	0.000545554	0.46303075959828016
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.46303075959828016
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000545554	0.46303075959828016
JOUBERT SYNDROME 8	0.000545554	0.46303075959828016
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000545554	0.46303075959828016
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.46303075959828016
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.000545554	0.46303075959828016
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.46303075959828016
611961 STEVENSON-CAREY SYNDROME	0.000545554	0.46303075959828016
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.46303075959828016
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000545554	0.46303075959828016
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.46303075959828016
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.46303075959828016
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.46303075959828016
JOUBERT SYNDROME 7	0.000545554	0.46303075959828016
NOONAN SYNDROME 5; NS5	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.46303075959828016
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.000545554	0.46303075959828016
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.000545554	0.46303075959828016
LIG4 SYNDROME	0.000545554	0.46303075959828016
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000545554	0.46303075959828016
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.46303075959828016
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.46303075959828016
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.46303075959828016
KAGAMI-OGATA SYNDROME	0.000545554	0.46303075959828016
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.000545554	0.46303075959828016
JOUBERT SYNDROME 2	0.000545554	0.46303075959828016
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.46303075959828016
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.46303075959828016
CHROMOSOME 1P36 DELETION SYNDROME	0.000545554	0.46303075959828016
NIEMANN-PICK DISEASE, TYPE C2	0.000545554	0.46303075959828016
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.46303075959828016
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000545554	0.46303075959828016
LISSENCEPHALY 1; LIS1	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.46303075959828016
HURLER SYNDROME	0.000545554	0.46303075959828016
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000545554	0.46303075959828016
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.46303075959828016
FUMARASE DEFICIENCY; FMRD	0.000545554	0.46303075959828016
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.000545554	0.46303075959828016
FRIAS SYNDROME	0.000545554	0.46303075959828016
LARSEN-LIKE SYNDROME	0.000545554	0.46303075959828016
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.46303075959828016
CHROMOSOME 10Q26 DELETION SYNDROME	0.000545554	0.46303075959828016
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.46303075959828016
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.46303075959828016
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.46303075959828016
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.46303075959828016
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000545554	0.46303075959828016
SCHINDLER DISEASE, TYPE I	0.000545554	0.46303075959828016
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000545554	0.46303075959828016
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.46303075959828016
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.000545554	0.46303075959828016
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.46303075959828016
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.46303075959828016
EMANUEL SYNDROME	0.000545554	0.46303075959828016
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.46303075959828016
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.46303075959828016
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.000545554	0.46303075959828016
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000545554	0.46303075959828016
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.46303075959828016
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000545554	0.46303075959828016
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.46303075959828016
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.46303075959828016
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.46303075959828016
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.46303075959828016
FOLATE MALABSORPTION, HEREDITARY	0.000545554	0.46303075959828016
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.46303075959828016
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.46303075959828016
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.46303075959828016
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000545554	0.46303075959828016
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.46303075959828016
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.46303075959828016
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.000545554	0.46303075959828016
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.46303075959828016
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.46303075959828016
COSTELLO SYNDROME; CSTLO	0.000545554	0.46303075959828016
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.46303075959828016
COACH SYNDROME	0.000545554	0.46303075959828016
CITRULLINEMIA, CLASSIC	0.000545554	0.46303075959828016
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.46303075959828016
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.46303075959828016
JOUBERT SYNDROME 1	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.46303075959828016
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.000545554	0.46303075959828016
C SYNDROME	0.000545554	0.46303075959828016
GAUCHER DISEASE, TYPE II	0.000545554	0.46303075959828016
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000545554	0.46303075959828016
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000545554	0.46303075959828016
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.46303075959828016
MACDERMOT-WINTER SYNDROME	0.000545554	0.46303075959828016
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.46303075959828016
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000545554	0.46303075959828016
LANDAU-KLEFFNER SYNDROME	0.000545554	0.46303075959828016
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000545554	0.46303075959828016
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.46303075959828016
KETOADIPICACIDURIA	0.000545554	0.46303075959828016
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.46303075959828016
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.46303075959828016
ARIMA SYNDROME	0.000545554	0.46303075959828016
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000545554	0.46303075959828016
VICI SYNDROME; VICIS	0.000545554	0.46303075959828016
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.000545554	0.46303075959828016
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.46303075959828016
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000545554	0.46303075959828016
HYDROXYKYNURENINURIA	0.000545554	0.46303075959828016
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000545554	0.46303075959828016
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.46303075959828016
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000545554	0.46303075959828016
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.46303075959828016
HARTNUP DISORDER	0.000545554	0.46303075959828016
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.46303075959828016
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.46303075959828016
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000545554	0.46303075959828016
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.46303075959828016
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.46303075959828016
KBG SYNDROME	0.000545554	0.46303075959828016
KABUKI SYNDROME 1	0.000545554	0.46303075959828016
PALLISTER-HALL SYNDROME	0.000545554	0.46303075959828016
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.46303075959828016
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.46303075959828016
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.46303075959828016
MYHRE SYNDROME	0.000545554	0.46303075959828016
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.46303075959828016
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.000545554	0.46303075959828016
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.46303075959828016
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.46303075959828016
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.46303075959828016
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.46303075959828016
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.46303075959828016
ANGELMAN SYNDROME	0.000545554	0.46303075959828016
ADENYLOSUCCINASE DEFICIENCY	0.000545554	0.46303075959828016
ADAMS-OLIVER SYNDROME 1; AOS1	0.000545554	0.46303075959828016
8P23.1 DUPLICATION SYNDROME	0.000545554	0.46303075959828016
12Q14 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
15Q13.3 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
XQ28 (MECP2) DUPLICATION	0.000545554	0.46303075959828016
3Q29 MICRODELETION SYNDROME	0.000545554	0.46303075959828016
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.46303075959828016
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.46303075959828016
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.46303075959828016
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.46303075959828016
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.46303075959828016
AUSTRALIA ANTIGEN	0.000545554	0.46303075959828016
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.46303075959828016
ARGININOSUCCINIC ACIDURIA	0.000545554	0.46303075959828016
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.46303075959828016
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.46303075959828016
ALSTROM SYNDROME; ALMS	0.000545554	0.46303075959828016
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.46303075959828016
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000545554	0.46303075959828016
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.46303075959828016
DIGEORGE SYNDROME; DGS	0.000545554	0.46303075959828016
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.46303075959828016
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.46303075959828016
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.46303075959828016
SMITH-MAGENIS SYNDROME; SMS	0.000545554	0.46303075959828016
SEPTOOPTIC DYSPLASIA	0.000545554	0.46303075959828016
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.000545554	0.46303075959828016
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.46303075959828016
RECOMBINANT CHROMOSOME 8 SYNDROME	0.000545554	0.46303075959828016
CURRARINO SYNDROME	0.000545554	0.46303075959828016
PRADER-WILLI SYNDROME; PWS	0.000545554	0.46303075959828016
PELGER-HUET ANOMALY; PHA	0.000545554	0.46303075959828016
CHAR SYNDROME	0.000545554	0.46303075959828016
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.46303075959828016
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.000545554	0.46303075959828016
MEHMO SYNDROME; MEHMO	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000545554	0.46303075959828016
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.46303075959828016
WEAVER SYNDROME	0.000545554	0.46303075959828016
WAARDENBURG-SHAH SYNDROME	0.000545554	0.46303075959828016
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.46303075959828016
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.46303075959828016
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000545554	0.46303075959828016
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME VI	0.000545554	0.46303075959828016
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.46303075959828016
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.46303075959828016
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.46303075959828016
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000545554	0.46303075959828016
SULFOCYSTEINURIA	0.000545554	0.46303075959828016
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.46303075959828016
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.46303075959828016
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.46303075959828016
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.46303075959828016
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.46303075959828016
ROTHMUND-THOMSON SYNDROME	0.000545554	0.46303075959828016
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.46303075959828016
REVESZ SYNDROME	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.46303075959828016
300270 ADRENOMYODYSTROPHY	0.000545554	0.46303075959828016
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.000545554	0.46303075959828016
BARATELA-SCOTT SYNDROME	0.000545554	0.46303075959828016
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.46303075959828016
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.46303075959828016
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.46303075959828016
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.46303075959828016
OGDEN SYNDROME; OGDNS	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 88	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 90	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000545554	0.46303075959828016
JOUBERT SYNDROME 10	0.000545554	0.46303075959828016
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.000545554	0.46303075959828016
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.46303075959828016
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 91; MRX91	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.46303075959828016
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000545554	0.46303075959828016
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.000545554	0.46303075959828016
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000545554	0.46303075959828016
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.000545554	0.46303075959828016
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.46303075959828016
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.000545554	0.46303075959828016
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.46303075959828016
ELEJALDE DISEASE	0.000545554	0.46303075959828016
NETHERTON SYNDROME; NETH	0.000545554	0.46303075959828016
LEIGH SYNDROME; LS	0.000545554	0.46303075959828016
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.46303075959828016
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000545554	0.46303075959828016
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000545554	0.46303075959828016
MUCOLIPIDOSIS IV; ML4	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.000545554	0.46303075959828016
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.000545554	0.46303075959828016
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.46303075959828016
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.46303075959828016
JAWAD SYNDROME	0.000545554	0.46303075959828016
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.46303075959828016
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.46303075959828016
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.46303075959828016
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.46303075959828016
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.46303075959828016
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.46303075959828016
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.46303075959828016
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.000545554	0.46303075959828016
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.46303075959828016
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.46303075959828016
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.46303075959828016
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.46303075959828016
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.000545554	0.46303075959828016
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000545554	0.46303075959828016
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.46303075959828016
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.46303075959828016
PYRUVATE CARBOXYLASE DEFICIENCY	0.000545554	0.46303075959828016
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000545554	0.46303075959828016
3MC SYNDROME 2	0.000545554	0.46303075959828016
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.000545554	0.46303075959828016
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.46303075959828016
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.46303075959828016
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.46303075959828016
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000545554	0.46303075959828016
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000545554	0.46303075959828016
PETERS-PLUS SYNDROME; PTRPLS	0.000545554	0.46303075959828016
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.000545554	0.46303075959828016
PELLAGRA-LIKE SYNDROME	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.000545554	0.46303075959828016
PEHO SYNDROME; PEHO	0.000545554	0.46303075959828016
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.46303075959828016
RAINE SYNDROME	0.000545554	0.46303075959828016
OROTIC ACIDURIA	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.46303075959828016
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.46303075959828016
LISSENCEPHALY 2; LIS2	0.000545554	0.46303075959828016
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000545554	0.46303075959828016
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.46303075959828016
NAVAJO NEUROHEPATOPATHY	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000545554	0.46303075959828016
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.46303075959828016
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.46303075959828016
ROIFMAN SYNDROME; RFMN	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.46303075959828016
SENIOR-LOKEN SYNDROME 9	0.000545554	0.46303075959828016
RING CHROMOSOME 14 SYNDROME	0.000545554	0.46303075959828016
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.46303075959828016
AU-KLINE SYNDROME; AUKS	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.000545554	0.46303075959828016
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000545554	0.46303075959828016
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.46303075959828016
NOONAN SYNDROME 9; NS9	0.000545554	0.46303075959828016
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.46303075959828016
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.46303075959828016
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.46303075959828016
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.46303075959828016
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.46303075959828016
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.46303075959828016
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.000545554	0.46303075959828016
AL-RAQAD SYNDROME; ARS	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.46303075959828016
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.46303075959828016
JOUBERT SYNDROME 24	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000545554	0.46303075959828016
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.000545554	0.46303075959828016
LAMB-SHAFFER SYNDROME	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.46303075959828016
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.46303075959828016
JOUBERT SYNDROME 26	0.000545554	0.46303075959828016
JOUBERT SYNDROME 25	0.000545554	0.46303075959828016
SECKEL SYNDROME 9; SCKL9	0.000545554	0.46303075959828016
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.46303075959828016
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.000545554	0.46303075959828016
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.46303075959828016
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.46303075959828016
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.000545554	0.46303075959828016
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000545554	0.46303075959828016
DESANTO-SHINAWI SYNDROME	0.000545554	0.46303075959828016
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.46303075959828016
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.46303075959828016
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000545554	0.46303075959828016
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.000545554	0.46303075959828016
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.46303075959828016
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.46303075959828016
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.46303075959828016
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000545554	0.46303075959828016
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.46303075959828016
CATEL-MANZKE SYNDROME; CATMANS	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.46303075959828016
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.46303075959828016
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.46303075959828016
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000545554	0.46303075959828016
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.46303075959828016
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000545554	0.46303075959828016
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.46303075959828016
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.46303075959828016
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.46303075959828016
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.46303075959828016
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000545554	0.46303075959828016
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000545554	0.46303075959828016
CHOPS SYNDROME; CHOPS	0.000545554	0.46303075959828016
WHITE-SUTTON SYNDROME; WHSUS	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000545554	0.46303075959828016
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000545554	0.46303075959828016
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.46303075959828016
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.46303075959828016
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.46303075959828016
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000545554	0.46303075959828016
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.46303075959828016
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.000545554	0.46303075959828016
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.46303075959828016
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.46303075959828016
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.46303075959828016
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.46303075959828016
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.46303075959828016
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.46303075959828016
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000545554	0.46303075959828016
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.000545554	0.46303075959828016
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.46303075959828016
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.46303075959828016
OPTIC ATROPHY 11; OPA11	0.000545554	0.46303075959828016
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.46303075959828016
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.46303075959828016
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.46303075959828016
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.46303075959828016
LISSENCEPHALY 8; LIS8	0.000545554	0.46303075959828016
IMMUNODEFICIENCY 49; IMD49	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.46303075959828016
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.000545554	0.46303075959828016
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.46303075959828016
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.000545554	0.46303075959828016
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000545554	0.46303075959828016
SHASHI-PENA SYNDROME; SHAPNS	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.46303075959828016
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000545554	0.46303075959828016
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.46303075959828016
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.46303075959828016
MECKEL SYNDROME 13; MKS13	0.000545554	0.46303075959828016
COHEN-GIBSON SYNDROME; COGIS	0.000545554	0.46303075959828016
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.46303075959828016
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.46303075959828016
RAHMAN SYNDROME	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000545554	0.46303075959828016
PEHO-LIKE SYNDROME; PEHOL	0.000545554	0.46303075959828016
POTOCKI-SHAFFER SYNDROME	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000545554	0.46303075959828016
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.46303075959828016
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000545554	0.46303075959828016
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000545554	0.46303075959828016
HAREL-YOON SYNDROME; HAYOS	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.46303075959828016
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.46303075959828016
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000545554	0.46303075959828016
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.46303075959828016
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.46303075959828016
COFFIN-SIRIS SYNDROME 5	0.000545554	0.46303075959828016
HEART AND BRAIN MALFORMATION SYNDROME	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000545554	0.46303075959828016
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.46303075959828016
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.46303075959828016
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000545554	0.46303075959828016
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.46303075959828016
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.46303075959828016
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.46303075959828016
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.000545554	0.46303075959828016
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000545554	0.46303075959828016
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.46303075959828016
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.46303075959828016
EVEN-PLUS SYNDROME	0.000545554	0.46303075959828016
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.46303075959828016
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.46303075959828016
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.46303075959828016
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000545554	0.46303075959828016
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000545554	0.46303075959828016
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.46303075959828016
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.46303075959828016
ZTTK SYNDROME; ZTTKS	0.000545554	0.46303075959828016
ALAZAMI-YUAN SYNDROME	0.000545554	0.46303075959828016
JOUBERT SYNDROME 28	0.000545554	0.46303075959828016
JOUBERT SYNDROME 27	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.46303075959828016
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.000545554	0.46303075959828016
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.46303075959828016
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.46303075959828016
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.46303075959828016
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.46303075959828016
MEIER-GORLIN SYNDROME 7	0.000545554	0.46303075959828016
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.000545554	0.46303075959828016
MIRAGE SYNDROME; MIRAGE	0.000545554	0.46303075959828016
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.000545554	0.46303075959828016
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.46303075959828016
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.46303075959828016
BARDET-BIEDL SYNDROME 2	0.000545554	0.46303075959828016
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.46303075959828016
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.46303075959828016
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.46303075959828016
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000545554	0.46303075959828016
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.46303075959828016
HOLOPROSENCEPHALY 11	0.000545554	0.46303075959828016
ADAMS-OLIVER SYNDROME 2; AOS2	0.000545554	0.46303075959828016
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.000545554	0.46303075959828016
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000545554	0.46303075959828016
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.46303075959828016
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.46303075959828016
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000545554	0.46303075959828016
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000545554	0.46303075959828016
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000545554	0.46303075959828016
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.000545554	0.46303075959828016
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000545554	0.46303075959828016
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.46303075959828016
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.46303075959828016
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.46303075959828016
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.46303075959828016
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.000545554	0.46303075959828016
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.46303075959828016
PONTINE TEGMENTAL CAP DYSPLASIA	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.000545554	0.46303075959828016
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.46303075959828016
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.46303075959828016
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.46303075959828016
COFFIN-SIRIS SYNDROME 4; CSS4	0.000545554	0.46303075959828016
COFFIN-SIRIS SYNDROME 3; CSS3	0.000545554	0.46303075959828016
COFFIN-SIRIS SYNDROME 2; CSS2	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.000545554	0.46303075959828016
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000545554	0.46303075959828016
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.46303075959828016
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.46303075959828016
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000545554	0.46303075959828016
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.46303075959828016
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.000545554	0.46303075959828016
JOUBERT SYNDROME 15	0.000545554	0.46303075959828016
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.46303075959828016
JOUBERT SYNDROME 14	0.000545554	0.46303075959828016
LISSENCEPHALY 4	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000545554	0.46303075959828016
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.46303075959828016
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.46303075959828016
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.46303075959828016
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.46303075959828016
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.46303075959828016
NOONAN SYNDROME 6; NS6	0.000545554	0.46303075959828016
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.000545554	0.46303075959828016
GABA-TRANSAMINASE DEFICIENCY	0.000545554	0.46303075959828016
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.46303075959828016
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.46303075959828016
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.000545554	0.46303075959828016
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000545554	0.46303075959828016
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000545554	0.46303075959828016
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.46303075959828016
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.46303075959828016
HADZISELIMOVIC SYNDROME	0.000545554	0.46303075959828016
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.46303075959828016
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.000545554	0.46303075959828016
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.000545554	0.46303075959828016
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.46303075959828016
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.000545554	0.46303075959828016
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.46303075959828016
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.46303075959828016
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.46303075959828016
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.46303075959828016
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.46303075959828016
WITTEVEEN-KOLK SYNDROME	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000545554	0.46303075959828016
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.000545554	0.46303075959828016
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.46303075959828016
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.46303075959828016
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.46303075959828016
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.000545554	0.46303075959828016
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.46303075959828016
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.46303075959828016
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000545554	0.46303075959828016
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.46303075959828016
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.46303075959828016
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.46303075959828016
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.46303075959828016
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.46303075959828016
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.46303075959828016
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.46303075959828016
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.46303075959828016
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.000545554	0.46303075959828016
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.46303075959828016
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000545554	0.46303075959828016
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.46303075959828016
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000545554	0.46303075959828016
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.46303075959828016
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.46303075959828016
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.46303075959828016
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000545554	0.46303075959828016
CHROMOSOME 5Q12 DELETION SYNDROME	0.000545554	0.46303075959828016
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000545554	0.46303075959828016
JOUBERT SYNDROME 21	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.46303075959828016
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.46303075959828016
SCHAAF-YANG SYNDROME; SHFYNG	0.000545554	0.46303075959828016
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000545554	0.46303075959828016
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000545554	0.46303075959828016
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.46303075959828016
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.000545554	0.46303075959828016
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.46303075959828016
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.46303075959828016
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.000545554	0.46303075959828016
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.46303075959828016
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.46303075959828016
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.46303075959828016
DESBUQUOIS DYSPLASIA 2; DBQD2	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.46303075959828016
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.46303075959828016
WEBB-DATTANI SYNDROME; WEDAS	0.000545554	0.46303075959828016
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000545554	0.46303075959828016
CULLER-JONES SYNDROME; CJS	0.000545554	0.46303075959828016
AICARDI-GOUTIERES SYNDROME 7	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.46303075959828016
XIA-GIBBS SYNDROME	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.46303075959828016
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.46303075959828016
SECKEL SYNDROME 8; SCKL8	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.46303075959828016
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.46303075959828016
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.000545554	0.46303075959828016
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.46303075959828016
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.46303075959828016
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000545554	0.46303075959828016
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000545554	0.46303075959828016
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.000545554	0.46303075959828016
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.46303075959828016
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.46303075959828016
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.46303075959828016
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.000545554	0.46303075959828016
ALAZAMI SYNDROME; ALAZS	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.46303075959828016
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000545554	0.46303075959828016
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.46303075959828016
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.000545554	0.46303075959828016
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.46303075959828016
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.46303075959828016
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.46303075959828016
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.46303075959828016
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.000545554	0.46303075959828016
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000545554	0.46303075959828016
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.46303075959828016
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.46303075959828016
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.46303075959828016
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.46303075959828016
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.46303075959828016
STEEL SYNDROME; STLS	0.000545554	0.46303075959828016
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.46303075959828016
TYSHCHENKO SYNDROME	0.000545554	0.46303075959828016
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.46303075959828016
